Evolution of the Food and Drug Administration Approach to Liver Safety Assessment for New Drugs: Current Status and Challenges
Crossref DOI link: https://doi.org/10.1007/s40264-014-0182-7
Published Online: 2014-10-29
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Senior, John R.
License valid from 2014-10-29